Private Trust Company’s BioNTech BNTX Stock Holding History

Private Trust Company’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-90	Closed	-$12K	–	2172
2022 Q3	$12K	Hold	90	–	–	﹤0.01%	1375
2022 Q2	$13K	Buy	+90	New	+$13.8K	﹤0.01%	1377

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Private Trust Company's BNTX Position: Q4 2022 in Review

Private Trust Company sold out of BioNTech (BNTX) in Q4 2022, closing a stake of 90 shares — an estimated $12K sold.

Private Trust Company first reported a position in BNTX in Q2 2022 and held it in 2 quarters. The position peaked at $13K in Q2 2022. 320 funds tracked by Wall St. Rank hold BNTX as of Q4 2022.

Private Trust Company reported no remaining BioNTech position as of Q4 2022 after selling out during the quarter.
Private Trust Company sold 90 BioNTech shares in Q4 2022, an estimated $12K.
Private Trust Company first reported a position in BioNTech in Q2 2022 and held it in 2 quarters.
Private Trust Company's BioNTech position peaked at $13K in Q2 2022.
320 funds tracked by Wall St. Rank held BioNTech as of Q4 2022.

Based on Private Trust Company's 13F filing for Q4 2022, filed 18 Jan 2023.